Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting.
Saved in:
| Title: | Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting. |
|---|---|
| Authors: | Ayuk FA; Department of Stem Cell Transplantation., Berger C; Department of Stem Cell Transplantation., Badbaran A; Department of Stem Cell Transplantation., Zabelina T; Department of Stem Cell Transplantation., Sonntag T; Department of Stem Cell Transplantation., Riecken K; Department of Stem Cell Transplantation., Geffken M; Institute for Transfusion Medicine., Wichmann D; Department of Intensive Care Medicine., Frenzel C; Department of Hematology and Oncology, and., Thayssen G; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Zeschke S; Department of Stem Cell Transplantation., Kröger N; Department of Stem Cell Transplantation., Fehse B; Department of Stem Cell Transplantation. |
| Source: | Blood advances [Blood Adv] 2021 Jun 08; Vol. 5 (11), pp. 2523-2527. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2473-9537 |
|---|---|
| DOI: | 10.1182/bloodadvances.2020003959 |
